Company Filing History:
Years Active: 2009-2013
Title: L Julie Huber: Innovator in Biomedical Research
Introduction
L Julie Huber is a distinguished inventor based in Newton, MA, with a remarkable portfolio of three patents in the field of biomedical research. She has made significant contributions to understanding and treating various disorders through innovative compounds and methodologies.
Latest Patents
Among her latest patents, Huber has developed SirT inhibitors that bind to NAD, described in the compound of formula (I). This invention includes methods for treating a range of disorders including neoplastic disorders, fat-cell related disorders, neurodegenerative disorders, and metabolic disorders. Another critical patent focuses on the modulation of cytochrome c acetylation, leveraging a SIR polypeptide to enable interventions that regulate lifespan and cell proliferation, impacting apoptosis and mitochondrial respiration.
Career Highlights
L Julie Huber is a prominent figure at Elixir Pharmaceuticals, Inc., where her research and innovative work have paved the way for breakthroughs in treatment methodologies. Her deep understanding of cellular mechanisms has been pivotal in her patent developments, positioning her as a leader in her field.
Collaborations
Throughout her career, Huber has collaborated with notable colleagues such as Jonathan M Solomon and Andrew Napper. These partnerships have enriched her research and contributed to the successful outcomes of her innovations, helping to push the boundaries of biomedical science.
Conclusion
L Julie Huber continues to be an influential inventor in the medical research community. Her patents not only highlight her ingenuity but also reflect her commitment to advancing treatment options for complex health issues. As she continues her work, her contributions are expected to make a lasting impact in the field.